Superoxide Dismutase 3 Limits Collagen-Induced Arthritis in the Absence of Phagocyte Oxidative Burst by Kelkka, Tiina et al.
Hindawi Publishing Corporation
Mediators of Inﬂammation
Volume 2012, Article ID 730469, 9 pages
doi:10.1155/2012/730469
Research Article
SuperoxideDismutase 3 Limits Collagen-Induced Arthritis in
the Absence of Phagocyte Oxidative Burst
TiinaKelkka,1,2,3 Juha Petteri Laurila,1,2 Outi Sareila,1 Peter Olofsson,4
Mikko Olavi Laukkanen,1,5 andRikard Holmdahl1,3
1Medicity Research Laboratory, University of Turku, Tykist¨ okatu 6 A, 20520 Turku, Finland
2Turku Doctoral Programme of Biomedical Sciences, Kiinamyllynkatu 13, 20520 Turku, Finland
3Medical Inﬂammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet,
171 77 Stockholm, Sweden
4Redoxis AB, Sahlgrenska Science Park, Medicinaregatan 8A, 413 46 G¨ oteborg, Sweden
5Fondazione SDN, 80143 Naples, Italy
Correspondence should be addressed to Rikard Holmdahl, rikard.holmdahl@ki.se
Received 14 September 2011; Revised 21 November 2011; Accepted 12 December 2011
Academic Editor: Christoph Aufricht
Copyright © 2012 Tiina Kelkka et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Extracellular superoxide dismutase (SOD3), an enzyme mediating dismutation of superoxide into hydrogen peroxide, has been
shown to reduce inﬂammation by inhibiting macrophage migration into injured tissues. In inﬂamed tissues, superoxide is
produced by the phagocytic NOX2 complex, which consists of the catalytic subunit NOX2 and several regulatory subunits
(e.g., NCF1). To analyze whether SOD3 can regulate inﬂammation in the absence of functional NOX2 complex, we injected
an adenoviral vector overexpressing SOD3 directly into the arthritic paws of Ncf1∗/∗ mice with collagen-induced arthritis.
SOD3 reduced arthritis severity in both oxidative burst-deﬁcient Ncf1∗/∗ mice and also in wild-type mice. The NOX2 complex
independent anti-inﬂammatory eﬀect of SOD3 was further characterized in peritonitis, and SOD3 was found to reduce
macrophage inﬁltration independently of NOX2 complex functionality. We conclude that the SOD3-mediated anti-inﬂammatory
eﬀect on arthritis and peritonitis operates independently of NOX2 complex derived oxidative burst.
1.Introduction
Extracellular superoxide dismutase (SOD3) is an enzyme
known to catalyze dismutation of the highly reactive, super-
oxide anion into longer-lived and more stable hydrogen per-
oxide [1].TheconsequencesofSOD3actioninthecellsreach
beyond the antioxidative functions, as it has been shown to
downregulate inﬂammation [2], stimulate cell proliferation
duringtissueinjuryrecovery[3],andtocounteractapoptosis
[4, 5]b ya ﬀecting cytokine production, cell signal transduc-
tion, and expression of survival-related genes.
The anti-inﬂammatory properties of SOD3 have been
studied in models of pulmonary disease and peritonitis
[2, 6]. Previous work with collagen-induced arthritis (CIA)
suggests that both genetic transfer of the SOD3 gene [7]a s
well as a small molecular SOD mimetic have the ability to
ameliorate arthritis [8]. The arthritis ameliorating eﬀect of
SOD3 was later conﬁrmed using SOD3 knock-out mice [9].
These results were explained on the basis that SOD3 acts as
an antioxidant and catalyses dismutation of superoxide into
hydrogen peroxide, thus reducing inﬂammation-induced
oxidative stress and restoring the oxidant balance in the
arthriticjoints[10,11].Thisexplanation,however,isdiﬃcult
to reconcile with the ﬁnding that animals naturally deﬁcient
in the induced oxidative burst in fact develop more severe
arthritis [12, 13].
The most potent producer of superoxide, the substrate
for SOD3, is the well-characterized phagocytic NOX2 com-
plex. In inﬂamed tissues NOX2 complex produces massive
amounts of superoxide upon activation in a process called
phagocyte oxidative burst. In addition to NOX2, superoxide
is produced from various other cellular sources, such as
from the mitochondria during cellular respiration and by
other members of the NOX enzyme family [14]. However, it2 Mediators of Inﬂammation
should be noted that during inﬂammation these superoxide
p r o d u c e r sa r en o tn e a r l ya se ﬃcient superoxide producers as
the NOX2 complex.
In the current work we studied the role of SOD3 in
collagen-induced arthritis (CIA) to understand whether the
therapeutic eﬀect of SOD3 on arthritis operates through
attenuating the biological eﬀects of the induced oxidative
burst produced by the NOX2 complex. To avoid artifacts
introduced by chemical inhibitors of NOX2 complex [14–
16] we used mice that genetically lack functional NOX2
complex. Thus we used wild-type (Ncf1+/+)a n dNcf1
mutated (Ncf1∗/∗)miceonB10.Qbackground.Thesestrains
diﬀer at only one SNP in the Ncf1 gene, which makes the
Ncf1∗/∗ strain unable to produce oxidative burst [13]. The
mutated mouse is more susceptible to induced arthritis due
to hyperactivated T cells [13], and also increased suscepti-
bility to thioglycollate peritonitis has been reported in the
Ncf1 knockout mouse [17]. Our results conﬁrm the pre-
viously documented anti-inﬂammatory role of SOD3 and
additionally, for the ﬁrst time, we show that it can down-
regulate both CIA and peritonitis even in the absence of
functional NOX2 complex and phagocyte oxidative burst.
2.MaterialsandMethods
2.1. Mice. The previously described Ncf1m1J (protein also
called p47phox) mouse [18], which carries a point mutation
globally and completely abolishing NOX2 complex derived
ROS production, has been backcrossed onto the B10.Q
background [13] and shown to contain only the causative
mutation using a 10k SNP typing chip. The mice were
housed under speciﬁc pathogen-free conditions in climate-
controlled environment and fed standard rodent chow and
water ad libitum at Turku University Central Animal Facility.
All experimental mice were sex- and age-matched, treatment
groups were blinded, and experimental groups were mixed
in cages in all experiments. The experiments were performed
in accordance with the national and EU guidelines and the
study was approved by the Oulu section of the national
Animal Experiment Board (El¨ ainkoelautakunta, ELLA) with
ethical approval numbers ESLH-2008-02873, ESLH-2008-
07941, and ESAVI-0000497/041003/2011.
2.2. Viral Expression Vectors Used in the Study. Replication
deﬁcient adenoviral E1-partially-E3-deleted AdBglII vectors
(developed from serotype Ad5) expressing rabbit SOD3
(Ade-SOD3) or bacterial β-galactosidase lacZ (Ade-LacZ)
[4] were used in both in vitro and in vivo experiments.
2.3. Collagen-Induced Arthritis. Collagen-induced arthritis
(CIA) was induced under isoﬂurane anesthesia by injecting
100μg rat type II collagen (puriﬁed from chondrosarcoma)
[19] emulsiﬁed in complete Freund’s adjuvant intradermally
at the base of the tail. Arthritis was boosted day 19 with
50μg rat type II collagen emulsiﬁed in incomplete Freund’s
adjuvant intradermally at the base of the tail. Disease
development was evaluated macroscopically three times a
week before the booster immunization and daily after the
boost [20]. One point was given for each swollen toe or joint
and ﬁve points for a swollen ankle, each paw having the
maximum of ﬁfteen points.
In the arthritis experiments Ade-SOD3, Ade-LacZ (vec-
torcontrol),andPBS(injectioncontrol)wereinjectedlocally
in the left front paw in 25μL injection volume containing 2,5
× 108 PFU virus. Injections were performed right after the
booster immunization during the same anesthesia at day 19,
before the onset of clinically apparent arthritis.
2.4. Peritonitis. Peritonitis experiments were performed as
described in [2]. Brieﬂy, mice were pretreated i.p. with
0.5 × 109 PFU Ade-SOD3, Ade-LacZ, or PBS three days
before peritonitis induction with 5% proteose peptone (BD
Difco, Sparks, MD, USA) and 10ng IL-1β (R&D Systems,
Minneapolis, MN, USA) in 1mL PBS. After 18 hours
peritoneal inﬁltrating cells were collected with 10mL ice-
cold RPMI cell culture medium. Cells from the peritoneal
lavage were counted and cytocentrifuged, slides were stained
with Reastain Diﬀ-Quick (Reagena, Toivala, Finland), and
diﬀerential counting was performed under a standard light
microscope. Experiments were pooled and the total cell
numbers are presented as percentual increase from the PBS
injection control. All peritonitis results were normalized to
adjust the vector control group (Ade-LacZ) mean to 100.
2.5. Cell Culture and In Vitro Extracellular Oxidative Burst.
COS-7 cells stably expressing all the essential components
of the NOX2 complex, namely, Cybb (gp91phox), Cyba
(p22phox), Ncf2 (p67phox), and Ncf1 (p47phox) were
provided by Dr. Mary C. Dinauer, Indiana University, USA
[21]. Cells were cultured in Dulbecco’s complete medium
(Gibco), 10% fetal calf serum, and penicillin-streptomycin
(Invitrogen, Paisley UK).
Extracellular superoxide production was quantiﬁed two
days after transduction (MOI 4) with adenoviral constructs
(Ade-SOD3 and Ade-LacZ) or medium control directly on
the 96-well cell culture plate using an isoluminol-enhanced
chemiluminescence method [22, 23]. Brieﬂy, the cells were
washed with PBS, and 100μL of isoluminol buﬀer was
added in each well. Isoluminol buﬀer contained isoluminol
(10μg/mL,Sigma-Aldrich)andhorseradishperoxidase-type
II (4U/mL, Sigma-Aldrich) dissolved in PBS with PMA
(200ng/mL, dissolved in DMSO, Sigma-Aldrich) and data
collection was initiated immediately and followed at 37◦Ca s
produced luminescence signal (Tecan Inﬁnite M200, Tecan,
M¨ annedorf, Switzerland) for 30 minutes. DMSO vehicle
controls represent the nonstimulated background values.
Representative data from the 15-min time point is reported.
2.6. In Vitro Intracellular Oxidative Burst. Red blood cells
were lysed from heparinized whole blood with hypotonic
lysis buﬀer and leukocytes were surface stained with APC
conjugated anti-Gr-1 (RB6-8C5) and eFluor 450 conjugated
anti-CD11b (M1/70) antibodies (eBioscience). Cells were
suspended in high-glucose D-MEM (Gibco) with antibiotics
without FCS and incubated for 10min at 37◦Cw i t h3μM
dihydro-rhodamine 123 (DHR-123; Molecular Probes andMediators of Inﬂammation 3
Invitrogen Life Technologies) followed by 20min activation
at 37◦C with 200ng/mL PMA (Sigma-Aldrich). After oxida-
tion by ROS, DHR-123 emits ﬂuorescence upon excitation
with the blue laser. The cells were washed into PBS and
acquired on LSR II ﬂow cytometer equipped with FACS
Diva software (BD Biosciences). Live cells were gated on the
cell type, and geometric means of respective populations
were analyzed with Flowing Software (Cell Imaging Core,
University of Turku).
2.7. In Vivo Oxidative Burst. Isoﬂurane anesthetized animals
with equal arthritis scores were injected intraperitoneally
with 20mg/kg L-012 probe (Wako Chemicals, Germany)
dissolved in PBS [24]. The luminescent signal was detected
with IVIS 50 bioluminescent system (Xenogen, USA) that
consists of an anesthesia unit built in a light tight chamber
equippedwithaCCDcamera.Imageacquisitionandanalysis
were performed with Living Image software (Xenogen).
2.8. Detection of Ade-SOD3 from the Injected Paws by RT-
PCR. RNA was isolated from the treated paws collected
d25 according to the manufacturer’s instructions with TRI
Reagent (Sigma-Aldrich). Glass homogenizers were used to
homogenize and separate the soft tissue from the bone. The
isolated RNA was DNAse treated with deoxyribonuclease I
(Fermentas) in the presence of Ribolock RNase Inhibitor
(Fermentas). The RNA was used for reverse transcription
reaction performed with Revert-Aid M-MULV (Fermentas).
TheacquiredcDNAwassubjectedtoQ-PCRwithAde-SOD3
(fw: GTG TGC TCC TGC CTG CTC, rev: CTG CTC CAC
CGT GTC TGA G) and β-actin speciﬁc primers (fw: CTA
AGG CCA ACC GTG AAA AG, rev: ACC AGA GGC ATA
CAG GGA CA), and the gene expression level was analyzed
using SYBR Green PCR Master Mix (Applied Biosystems),
iCycler iQ Multicolor Real-Time PCR Detection System
(Bio-Rad), and the iCycler (version 3.1) software. Ade-SOD
signal was normalized against β-actin expression levels and
the results are reported as fold change from the Ade-LacZ
group mean denoted as 1.
2.9. Statistics. Quantitative data are expressed as ± SEM.
Statistical signiﬁcance was analyzed by using two-tailed
Student’s t-test or if more than two groups were analyzed
one-way ANOVA with LSD post hoc analysis was run using
IBM SPSS Statistics 19 software (SPSS Inc.), P<0.05 is
considered as statistically signiﬁcant.
3. Results
3.1. Ade-SOD3 Produced Enzymatically Active SOD3 In Vitro.
Adenoviral SOD3 gene delivery reduced the superoxide
predominant ROS signal 37% compared to the Ade-LacZ
control virus when investigated two days after transduction
with Ade-SOD3 and Ade-LacZ viruses (Figure 1).
3.2. SOD3 Downregulated Arthritis. Mice started to develop
mild, clinically apparent arthritis at day 20 and made a
full response, mean arthritis scores reaching 7 (out of the
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Figure 1: The amount of extracellular ROS is reduced by SOD3.
Adenoviral vector coding for SOD3 (Ade-SOD3) signiﬁcantly
reduced the amount of extracellular ROS produced by COS cells
expressing all functional components of the NOX2 complex, when
compared to the Ade-LacZ control virus.
maximum of 15) in Ade-Laz treated and 3 points in Ade-
SOD3-treated mice some days later. The mean disease score
in the treated paws was lower in the Ade-SOD3-treated
group when compared to the Ade-LacZ-injected control
group, and the diﬀerence reached statistical signiﬁcance at
d26 (Figure 2(a)). The treatment eﬀect was only seen in the
treated paw, while there were no diﬀerences between the
treatment groups in sum scores of the three untreated paws
(see Supplementary Figure 1(a) in supplementary material
available online at doi: 10.1155/2012/730469) highlighting
the local character of the used gene therapy vector expressing
SOD3.
Both virus vector treated groups showed elevated arthri-
tis scores in the treated paws when compared to the PBS-
injected control paws in the injection control group. This
diﬀerence is illustrated in Figure 2(b), where Ade-LacZ-
treated paws are shown to have larger increase in arthritis
score than the Ade-SOD3-treated paws.
3.3. SOD3 Downregulated Arthritis in the Absence of Func-
tional NOX2 Complex. Starting from d20 the Ncf1∗/∗ mice
started to develop arthritis with signiﬁcantly higher mean
score than the wild-type mice. Interestingly, the mutated
mice without functional NOX2 complex derived superoxide
production also responded to Ade-SOD3 treatment. Ade-
SOD3-treated paws of the Ncf1∗/∗ mice had signiﬁcantly
lower mean disease score than the Ade-LacZ-treated vector
control paws at days 24 and 25 after arthritis induction.
Similarly to the wild-type mice, the diﬀerence in the mean
arthritis score in NOX2 complex deﬁcient mice was observed
when SOD3 was highly expressed from the adenoviral vector
(Figure 3(a))[ 4]. No diﬀerences were observed between
the treatment groups in the sum scores of the untreated
paws(SupplementaryFigure1(b))againsupportingthelocal
character of the immunomodulatory eﬀect of Ade-SOD3
treatment.4 Mediators of Inﬂammation
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Figure 2: SOD3 downregulated arthritis in wild-type B10.Q mice. Adenovirally expressed SOD3 reduced arthritis severity in the treated
paws (a) in wild-type B10.Q mice (Ade-SOD3 n = 6, Ade-lacZ n = 7). When compared to the PBS-treated injection control (n = 8) group,
Ade-SOD3-treated mice had less increase in the arthritis score in the treated paw than the Ade-LacZ-treated control mice (b).
0
2
4
6
8
10
12
14
d23 d24 d25 d26
Ade-LacZ
Ade-SOD3
Day after immunization
M
e
a
n
 
s
c
o
r
e
∗
∗
(a)
Ade-SOD3
Ade-LacZ
0
1
2
3
4
5
6
7
8
d24 d25 d26
∗ ∗
D
i
f
f
.
 
t
o
 
P
B
S
 
g
r
o
u
p
(b)
Figure 3: SOD3 downregulated arthritis in the absence of functional NOX2 complex. Arthritis severity was signiﬁcantly reduced in Ade-
SOD3-treated paws of mice lacking functional oxidative burst when compared to the control vector-treated paws (a). Shown is pooled data
from two independent experiments (Ade-SOD3 n = 22, Ade-lacZ n = 23). The diﬀerence in arthritis score in the treated paw between the
PBS-treated control mice (n = 10) and Ade-SOD3-treated mice was smaller than the diﬀerence between PBS-treated and Ade-LacZ-treated
mice at days 24 and 25 (b).
Similarly to the wild-type mice, Ade-SOD3 treatment
in Ncf1∗/∗ paws induced signiﬁcantly smaller diﬀerence
between the virus-treated and PBS-injected paws than
Ade-LacZ virus injection (signiﬁcant d24 and d25 after
immunization), again conﬁrming the arthritis limiting eﬀect
of SOD3 (Figure 3(b)). The experiment was repeated and
as the experiments were well reproduced, data from both
experiments was combined for analysis.
3.4. SOD3 Limited Peritonitis Both in the Presence and
Absence of Phagocyte Oxidative Burst. SOD3 expression
signiﬁcantly reduced the number of peritoneal inﬁltrating
cells in proteose peptone and IL-1β induced peritonitis in
wild type mice (Figure 4(a)). The decrease in inﬁltrating
leukocytes was mainly due to a lowered number of inﬁltrat-
ing macrophages (Figure 4(b)), which well corresponds with
the macrophage phase of peritonitis taking place three daysMediators of Inﬂammation 5
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Figure4:PeritonitisislimitedbySOD3.Ade-SOD3-treatedmicehadlessperitonealinﬁltratingcellsafterperitonitisinductionwithproteose
peptone and IL-1β than Ade-LacZ-treated control mice (a) (n = 5). The reduction in cell number was mainly due to diminished peritoneal
macrophage population (b) (Nf = neutrophil, Mf = macrophage, Lc = lymphocyte).
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Figure 5:PeritonitisislimitedbySOD3intheabsenceoffunctionalNOX2complex.Similarlytowild-typemice,Ade-SOD3-treatedNcf1∗/∗
mice had less peritoneal inﬁltrating macrophages than the Ade-LacZ-treated vector controls in the proteose peptone and IL-1β-induced
peritonitis model (a). Normalized total cell numbers (b) show signiﬁcant decrease in inﬁltrating macrophage population. Shown is pooled
data from two independent experiments (n = 10) (Nf = neutrophil, Mf = macrophage, Lc = lymphocyte).
after virus injection and 18 hours after peritonitis induction.
Bothvirus-treatedgroupshadmoreinﬁltratingcellsthanthe
PBS-injected control mice.
Similarly as in the wild-type mice Ade-SOD3 was shown
to reduce the number of inﬁltrating cells in the peritoneal
cavity of Ncf1∗/∗ mice when compared to Ade-LacZ-treated
mice. The diﬀerence was due to a signiﬁcantly lowered
number of inﬁltrating macrophages in the Ade-SOD3-
treated mice (Figures 5(a) and 5(b)).
3.5. Ncf1∗/∗ Mice Lack Oxidative Burst In Vivo and In Vitro.
In the wild-type mouse both severely inﬂamed paws (right
hind leg and right front paw) emitted strong ROS-induced
L-012 luminescence signal, while in spite of the severe
inﬂammation, no luminescent signal was detected from the
Ncf1∗/∗ mice (severe arthritis with arthritis score of 15 in
both front paws and milder symptoms in the left hind leg)
(Figure 6(a)). The intraperitoneal L-012 injection site emit-
ted similar background signal in both genotypes.
Monocytes (CD11b-POS, Gr-1-LO, or Gr-1-NEG) and
granulocytes (Gr-1-HI, CD11b-POS) from Ncf1∗/∗ mice
wereunableto generateeﬃcientROSproduction upon PMA
stimulation, while phagocytes from the wild-type animals
responded to PMA stimulation and induced signiﬁcant
increase in DHR-123 derived ﬂuorescence signal detected by
ﬂow cytometry (Figures 6(c) and 6(d)).
3.6. Ade-SOD3 Expression In Vivo. Quantitative RT-PCR re-
vealed a A 5.5-fold (FC, fold change) expression of adenovi-
rally produced SOD3 mRNA in the Ade-SOD3-treated joints6 Mediators of Inﬂammation
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Figure 6: No oxidative burst was detected from the Ncf1 mutated mice. In vivo imaging with the ROS sensitive L-012 probe revealed a bright
luminescent signal from the inﬂamed wild-type paws with CIA, while no signal was detected from Ncf1∗/∗ mice with comparable arthritis
severity (a). Imaging was reproduced in two independent experiments with similar results. Expression of SOD3 by Ade-SOD3 expression
vector in the treated paws was conﬁrmed by Q-RT-PCR (n = 7/group) (b). Ex vivo oxidative burst was measured from phagocytes from
Ncf1∗/∗ (n = 5) and wild-type mice (n = 6) by using DHR-123 assay with and without (w/o) PMA stimulation. Neither macrophages (c)
nor neutrophils (d) from the Ncf1∗/∗ mice were able to exert a measureable oxidative burst.
collected at d25 when compared to the Ade-LacZ-treated
v e c t o rc o n t r o lp a w s( Figure 6(b)).
4. Discussion
SOD3 is an enzyme that has been shown to give rise to
therapeutic responses in damaged tissues such as reduced
ischemia-reperfusion injury [25], arthritis [7], peritonitis
[2], hind limb injury [3], and lung injury [6] models. These
tissue healing promoting and anti-inﬂammatory eﬀects
induced by SOD3 are accompanied by reduced macrophage
inﬁltration [2], inhibition of oxidative fragmentation of the
extracellular matrix matrix [26], decreased apoptosis [4, 5],
and enhanced cell proliferation [27]. The beneﬁcial eﬀects
of SOD3 are mostly explained by its antioxidant properties
and reduction of oxidative stress in the injured tissues.
However, in this report we show that overexpression of
SOD3 downregulated inﬂammation even in the absence of
phagocyte oxidative burst, thus highlighting the capacity of
SOD3 to aﬀect cellular processes independently of NOX2
complex’ superoxide production.
The adenoviral gene expression system used in this work
reaches its maximal expression around three days after the
injection, after which the vector is eliminated by the immune
system and the expression of the transgene slowly decreases
to undetectable levels 14 days after the initial injection
[4]. We conﬁrmed the presence of virally delivered SOD3
mRNA in the paws d25 and thus conﬁrmed that the decrease
in arthritis severity coincided with substantial adenovirus
drivenSOD3expression.Similarly,pretreatingthemicethreeMediators of Inﬂammation 7
days before induction of peritonitis allowed us to analyze the
eﬀect of SOD3 during substantial SOD3 expression in the
peritoneal cavity.
The percentual treatment eﬀect in both inﬂamma-
tion models was comparable with the eﬀect previously
obtained with transgenic SOD3 overexpression in pul-
monary emphysema [26]. Similarly, the degree of SOD3-
inducedmacrophageinﬁltrationinhibitioninperitonitiswas
similar as reported previously [2] .E v e nt h o u g hS O D 3i sa n
importantlocalregulatoroftheacuteinﬂammatoryreaction,
it is obvious that there area number ofother factorsaﬀecting
inﬂammation severity in vivo.
The physiological function of SOD3 is to dismutate
extracellular superoxide into hydrogen peroxide. When the
NOX2 complex is not functional, there are still a number of
other enzymes and enzyme complexes producing superoxide
in the inﬂamed tissue. NOX1 has been reported to worsen
hyperoxia-inducedacutelunginjuryinmice[28],andNOX4
has been suggested to stimulate microglial IL-6 expression
[29] and to hamper neurodegeneration after poststroke
ischemia reperfusion injury [30]. However, only NOX2 is
abundantly expressed on phagocytes and thus recruited
to inﬂammatory foci. Other NOX family members are
expressed on other cell types than phagocytes and their ROS
production is not upregulated during inﬂammation.
In addition to the NOX family enzymes, superoxide
is also produced during mitochondrial respiration at lev-
els corresponding to the general metabolic rate in the
tissue. Mitochondrial superoxide has also been linked to
TLR2/4 signaling [31] and is also suggested as a pathologic
mechanism in tissue injury [32]. All these superoxide
generating processes, however, cannot compensate for the
massive production of ROS by the NOX2 complex during
inﬂammation as the arthritic paws of Ncf1∗/∗ mice emitted
no detectable luminescence signal when probed with L-012
dye (Figure 6(a)). L-012 reacts with any radical to produce
light and cannot be used to distinguish between superoxide
and hydrogen peroxide in vivo.
As a tool to study the NOX2 complex dependency of
SOD3, we used Ncf1 mutated mice, in which a splice site
point mutation abolishes the production of NCF1 protein
leading to complete loss of NOX2 complex derived oxidative
burst. In line with previous reports, arthritis severity was
signiﬁcantly higher in Ncf1∗/∗ animals when compared to
B10.Q wild-type mice [13]. Mutated mice also developed
arthritis quicker after the booster allowing us to work with a
more homogenous and extremely well reproducible disease
model. Better arthritis synchronization in the mutated
mouse model together with larger treatment groups resulted
in less variability and increased statistical power in data anal-
ysis. In proteose peptone-induced peritonitis we observed no
diﬀerence between the genotypes. The use of Ncf1 mutant
mice allowed us to avoid pit falls associated with the use
of chemical NOX2 complex inhibitors such as DPI and
apocynin, which are not speciﬁc for the NOX2 complex,
do not provide full suppression of superoxide production
and additionally profoundly aﬀect various other cellular
processes [14–16].
In both arthritis and peritonitis, adenoviral gene expres-
sion vectors locally enhanced inﬂammation. The arthritis
enhancing eﬀect was restricted to the treated paw, as the
virus-injected groups did not diﬀer from the PBS-injected
control group when their nontreated paws were analyzed.
This is in line with previous reports where intra-articular
injections of adenoviral gene expression vectors have been
shown to induce increased paw swelling and elevated levels
of inﬂammation mediators [33, 34]. Intravenous injection
routehasnotgivenrisetoenhancedarthritis[35–37],buthas
triggered liver inﬂammation; liver being the primary target
of systemically administered adenoviral vectors [35]. The
immunogenicity of the adenoviral gene expression systems
is well documented in the literature [38–40].
ROS regulate a number of physiological and disease-
related pathways in humans. SOD3 polymorphisms are asso-
ciated with COPD [41], coronary artery disease, myocardial
infarction [42] as well as acute lung injury and related
mortality [43]. Additionally, SOD3 has been reported to be
downregulated in thyroid cancer tumors [44]. Both SOD3
and Ncf1 are highly conserved ROS regulators [45]. There is
also genetic [46] and functional [47] evidence linking Ncf1
to human diseases.
5. Conclusions
We report that SOD3 limits inﬂammation in CIA and
peritonitis both in the presence and in the absence of
phagocyte oxidative burst. The anti-inﬂammatory function
of SOD3 is not compromised by the lack of functionality
of the NOX2 complex as both Ncf1+/+ and Ncf1∗/∗ mice
develop milder inﬂammation when treated with SOD3.
Thus,weconcludethattheanti-inﬂammatoryeﬀectofSOD3
is not dependent on superoxide produced by the NOX2
complex derived phagocyte oxidative burst and thus acts via
other signaling pathways.
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